/ACST.V
ACST.V Stock - Acasti Pharma Inc.
Healthcare|BiotechnologyTSXV
$0.58+1.75%
+$0.01 (+1.75%) • Mar 27
51
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.7
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.71
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.64
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ACST.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.57 – $0.59
TARGET (TP)$0.67
STOP LOSS$0.53
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.22
52W High$1.51
52W Low$0.47
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $14.25M | $18.45M | $19.58M | $11.94M | $7.63M |
| Gross Profit | $-52,966,000 | $-62,495,000 | $-33,549,000 | $-34,370,000 | $-14,336,000 |
| Gross Margin | -371.7% | -338.8% | -171.3% | -287.8% | -187.9% |
| Operating Income | $-73,155,000 | $-81,674,000 | $-53,285,000 | $-51,085,000 | $-21,180,000 |
| Net Income | $-64,915,000 | $-75,665,000 | $-44,082,000 | $-43,037,000 | $-16,237,000 |
| Net Margin | -455.6% | -410.2% | -225.1% | -360.4% | -212.8% |
| EPS | $-0.99 | $-2.30 | $-1.69 | $-2.41 | $-17.76 |
Company Overview
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ACST.VBeat Rate
50%
Last 8 quarters
Avg Surprise
-24.5%
EPS vs Estimate
Beats / Misses
4/4
Last 12 quarters
Latest EPS
$-23.39
Q4 2023
EPS Surprise History
Q1 22
-37.5%
$-0.11vs$-0.08
Q1 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
+35.7%
$-0.09vs$-0.14
Q1 23
No data
Q3 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2024 | Feb 12, 2024 | — | — | — | — |
Q4 2023 | Nov 13, 2023 | — | $-23.39 | — | — |
Q3 2023 | Aug 9, 2023 | — | $-0.29 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.37 | — | — |
Q1 2023 | Feb 14, 2023 | $-0.14 | $-0.09 | +35.7% | ✓ BEAT |
Q4 2022 | Nov 14, 2022 | — | $-0.35 | — | — |
Q3 2022 | Aug 11, 2022 | — | $-0.29 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.50 | — | — |
Q1 2022 | Feb 14, 2022 | $-0.08 | $-0.11 | -37.5% | ✗ MISS |
Q4 2021 | Nov 10, 2021 | — | $-0.77 | — | — |
Q3 2021 | Aug 12, 2021 | — | $-0.65 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.66 | — | — |
Q1 2021 | Feb 9, 2021 | $-0.41 | $-0.59 | -43.2% | ✗ MISS |
Q4 2020 | Nov 16, 2020 | $-0.64 | $-0.10 | +84.4% | ✓ BEAT |
Q3 2020 | Aug 13, 2020 | $-0.56 | $-0.55 | +1.8% | ✓ BEAT |
Q1 2020 | Mar 31, 2020 | — | $-0.60 | — | — |
Q1 2020 | Feb 14, 2020 | $-1.03 | $-0.54 | +47.9% | ✓ BEAT |
Q4 2019 | Nov 13, 2019 | $-0.72 | $-2.72 | -277.8% | ✗ MISS |
Q3 2019 | Aug 14, 2019 | $-1.12 | $-1.20 | -7.1% | ✗ MISS |
Q1 2019 | Mar 31, 2019 | — | $-12.40 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ACST.V
What is ACST.V's current stock price?
Acasti Pharma Inc. (ACST.V) is currently trading at $0.58 per share. The stock has moved +1.75% today.
What is the analyst price target for ACST.V?
No analyst price targets are currently available for this stock.
What sector is Acasti Pharma Inc. in?
Acasti Pharma Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the TSXV exchange.
What is ACST.V's market cap?
Acasti Pharma Inc. has a market capitalization of $0.03 billion, making it a small-cap company.
Does ACST.V pay dividends?
No, Acasti Pharma Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAEZS.TO
Aeterna Zentaris Inc.
$8.29
Mkt Cap: $0.0B
GTMS.TO
Greenbrook TMS Inc.
$0.97
Mkt Cap: $0.0B
HS.CN
HS GovTech Solutions Inc.
$0.53
Mkt Cap: $0.0B
IBT.V
IBEX Technologies Inc.
$1.45
Mkt Cap: $0.0B
IMV.TO
IMV Inc.
$1.12
Mkt Cap: $0.0B
MMEN.CN
MedMen Enterprises Inc.
$0.02
Mkt Cap: $0.0B
REUN.TO
Reunion Neuroscience Inc.
$1.42
Mkt Cap: $0.0B
THNK.V
Think Research Corporation
$0.32
Mkt Cap: $0.0B
VIN.CN
Vinergy Capital Inc.
$0.20
Mkt Cap: $0.0B
YOUR.CN
YourWay Cannabis Brands Inc.
$0.09
Mkt Cap: $0.0B
Explore stocks similar to ACST.V for comparison